Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Gordon Carl L
Relationship:   Director, 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   5,900    

Indirect Shares

   35,147,503      
Direct Value   $9,617    

Indirect Value

   $618,034,826      
Total Shares   35,153,403      
Total Value   $618,044,443      


Adicet Bio, Inc $9,617 Adicet Bio, Inc $9,617
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    6   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    5   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   3.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Acadia Pharmaceuticals Inc ACAD Director 2004-06-02 0 2005-04-20 1,395,612    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2005-12-02 0 2005-12-02 1,100,000    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Director 0 2011-02-08 2,828,941    Premium*  
            Amarin Corp Plc AMRN Director 2011-02-28 0 2012-09-04 5,700    Premium*  
            Acceleron Pharma Inc XLRN Director 0 2013-09-18 8,006    Premium*  
            Intellia Therapeutics, Inc. NTLA Director 2016-05-11 0 2016-05-11 2,662,180    Premium*  
            Selecta Biosciences Inc SELB Director, 10% Owner 0 2016-06-27 1,825,415    Premium*  
            X4 Pharmaceuticals Inc XFOR Director, 10% Owner 2017-11-20 0 2017-11-20 1,868,966    Premium*  
            Armo Biosciences Inc ARMO Director 2018-01-30 0 2018-06-22 0    Premium*  
            Alector, Inc. ALEC Director, 10% Owner 2019-02-11 0 2019-02-11 203,200    Premium*  
            Turning Point Therapeutics, Inc. TPTX Director 2019-04-22 0 2019-04-22 2,027,550    Premium*  
            Prevail Therapeutics Inc. PRVL Director, 10% Owner 0 2021-01-22 0    Premium*  
            Keros Therapeutics, Inc. KROS Director 2020-04-13 0 2020-04-13 1,119,812    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director 2020-04-24 0 2021-03-30 2,212,571    Premium*  
            Adicet Bio, Inc ACET 2023-06-01 5,900 2024-01-25 2,930,527    Premium*  
            Kinnate Biopharma Inc. KNTE Director, 10% Owner 2020-12-07 0 2024-04-03 0    Premium*  
            Terns Pharmaceuticals, Inc. TERN Director, 10% Owner 2021-02-09 0 2022-12-23 7,619,135    Premium*  
            Disc Medicine, Inc IRON Director, 10% Owner 0 2021-02-05 5,826,224    Premium*  
            Theseus Pharmaceuticals, Inc. THRX Director, 10% Owner 2021-10-12 0 2024-02-14 0    Premium*  
            Arrivent Biopharma, Inc. AVBP Director, 10% Owner 2024-01-30 0 2024-01-30 1,513,664    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-11-07 4 B $5.21 $1,000,320 I/I 192,000 16,734,518 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-21 4 B $9.97 $1,115,603 I/I 111,896 16,542,652 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-20 4 B $9.95 $348,250 I/I 35,000 16,430,756 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-19 4 B $9.97 $114,864 I/I 11,521 16,395,756 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-13 4 B $9.43 $163,328 I/I 17,320 16,384,235 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-12 4 B $10.06 $190,104 I/I 18,897 16,366,915 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-11 4 B $9.81 $89,319 I/I 8,500 16,348,018 2.25 -
PRVL Prevail Therapeutics Inc. Director   –       •       •   2019-06-24 4 B $17.00 $14,999,984 I/I 882,352 13,822,463 2.25 -
PRVL Prevail Therapeutics Inc. Director   –       •       •   2019-06-24 4 A $0.00 $0 I/I 10,510,111 12,940,111 0 -
IRON Disc Medicine, Inc Director   –       •       •   2021-02-05 3 IO $0.00 $0 I/I 0 5,826,224 -
TERN Terns Pharmaceuticals, In... Director   –       •       •   2022-12-23 4 B $7.25 $1,000,000 I/I 137,931 4,882,854 2.25 %
KNTE Kinnate Biopharma Inc. Director   –       •      –    2022-02-15 4 B $9.96 $89,640 I/I 9,000 3,509,030 2.1 -
KNTE Kinnate Biopharma Inc. Director   –       •      –    2022-02-14 4 B $9.89 $305,486 I/I 30,700 3,500,030 2.1 -
KNTE Kinnate Biopharma Inc. Director   –       •      –    2022-02-11 4 B $10.22 $1,594,320 I/I 156,000 3,469,330 2.1 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2011-02-08 4 B $7.00 $3,749,998 I/I 535,714 2,828,941 2.1 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •       •   2020-04-28 4 A $0.00 $0 I/I 2,484,467 2,765,717 0 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-11 4 AS $33.04 $1,934,525 I/I (58,551) 2,707,166 0 -
NTLA Intellia Therapeutics, In... Director   –       •      –    2016-05-11 4 B $18.00 $4,500,000 I/I 250,000 2,662,180 2.1 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-12 4 AS $30.29 $2,741,881 I/I (90,521) 2,616,645 0 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-15 4 AS $29.14 $2,599,579 I/I (89,210) 2,527,435 0 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-16 4 AS $27.72 $1,146,305 I/I (41,353) 2,486,082 0 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-17 4 AS $28.43 $534,200 I/I (18,790) 2,467,292 0 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-18 4 AS $28.03 $169,834 I/I (6,059) 2,461,233 0 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-19 4 AS $26.47 $563,149 I/I (21,275) 2,439,958 0 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •      –    2021-03-22 4 AS $26.47 $203,104 I/I (7,673) 2,432,285 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us